,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
the enhertu data presented at asco received a standing ovation for its ability to halt disease progression and extend overall survival for her-2 low breast cancer patients. we cannot cure cancer yet, but the hope of it glimmers on the horizon.
SVP, Strategic Development at EVERSANA Intouch, Founder at Seamripper, Adjunct Faculty @TCU, aspiring theologian @PerkinsSMU Alum: @TAMU @SCADdotedu